Merck (MRK) Debt Ratio (2009 - 2026)
Merck (MRK) reported Debt Ratio of 0.38 for Q1 2026, up 26.11% year-over-year from 0.3 in Q1 2025, and up 5.88% quarter-over-quarter from 0.36 in Q4 2025.
Merck (MRK) Debt Ratio (2009 - 2026) Analysis & Trends
Merck (MRK) has 18 years of Debt Ratio data on file, last reported at 0.38 in Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.38, up 26.11% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.38 (up 26.11% YoY), and the FY2025 annual result was 0.36, up 13.76% from the prior year.
- Debt Ratio advanced to 0.38 in Q1 2026 per MRK's latest filing, from 0.36 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.38 in Q1 2026 and troughed at 0.28 in Q4 2022.
- A 5-year average of 0.32 and a median of 0.32 in 2025 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2022 and 2026: Debt Ratio retreated 13.36% in 2022, then grew 26.11% in 2026.
- A 5-year view of Debt Ratio shows it stood at 0.28 in 2022, then advanced by 16.88% to 0.33 in 2023, then slipped by 3.56% to 0.32 in 2024, then increased by 13.76% to 0.36 in 2025, then grew by 5.88% to 0.38 in 2026.
- Business Quant data shows MRK's Debt Ratio at 0.38 in Q1 2026, 0.36 in Q4 2025, and 0.32 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -0.22 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 0.37 |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 0.27 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 0.47 |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 0.38 |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 0.62 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 0.39 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 0.31 |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 0.51 |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.38 |
| Dec 31, 2025 | 0.36 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.30 |
| Mar 31, 2025 | 0.30 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.32 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.33 |
| Sep 30, 2023 | 0.33 |
| Jun 30, 2023 | 0.35 |
| Mar 31, 2023 | 0.29 |
| Dec 31, 2022 | 0.28 |
| Sep 30, 2022 | 0.28 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.31 |
| Sep 30, 2021 | 0.28 |
| Jun 30, 2021 | 0.29 |